Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | KCNN4 | O15554 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 2/20 | 0.39 |
| ▸ | HTR2C | P28335 | 2/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | KIF11 | P52732 | 1/20 | 0.38 |
| ▸ | KCNA3 | P22001 | 2/20 | 0.36 |
| ▸ | GLA | P06280 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL28296949 | 0.97 | KCNN4 (0.52) | TSHRALDH1A1TDP1KCNN4LMNA | |
| Formaldehyde SCHEMBL27601295 | 0.93 | ALDH1A1 (0.44) | TSHRALDH1A1TDP1KCNN4LMNA | |
| Chlorobenzene SCHEMBL28295200 | 0.91 | TSHR (0.50) | TSHRALDH1A1TDP1KCNN4LMNA | |
| SCHEMBL27635853 | 0.89 | ALDH1A1 (0.41) | TSHRALDH1A1TDP1KCNN4LMNA | |
| Formamide SCHEMBL28296947 | 0.87 | KCNN4 (0.44) | TSHRALDH1A1TDP1KCNN4LMNA | |
| SCHEMBL7571745 | 0.83 | KCNN4 (0.48) | TSHRALDH1A1TDP1KCNN4LMNA | |
| Formic Acid Methyl Ester SCHEMBL28296946 | 0.83 | TDP1 (0.38) | TSHRALDH1A1TDP1KCNN4LMNA | |
| SCHEMBL27759221 | 0.83 | CYP2A6 (0.54) | TSHRALDH1A1TDP1KCNN4LMNA | |
| SCHEMBL6683028 | 0.81 | KCNN4 (0.46) | TSHRALDH1A1TDP1KCNN4LMNA | |
| SCHEMBL28826593 | 0.81 | KCNN4 (0.46) | TSHRALDH1A1TDP1KCNN4LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1343 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115745457-A | High-adaptability concrete superplasticizer, preparation method and application thereof | 南京博特新材料有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-115725035-A | Slump-retaining concrete superplasticizer, preparation method and application thereof | 博特新材料泰州有限公司 | 2023-03-03 | — | — | CN | claimed |
| CN-107973812-B | A method of preparing aryl boric acid neopentyl glycol esters compound | 苏州大学 | 2019-08-13 | — | — | CN | claimed |
| JP-57154134-A | — | — | None | — | — | JP | disclosed |
| US-12030904-B2 | Phospholipid compounds and uses thereof | GILEAD SCIENCES, INC. (US) | 2024-07-09 | — | — | US | disclosed |
| US-12030853-B2 | MASP-2 inhibitors and methods of use | OMEROS CORPORATION (US) | 2024-07-09 | — | — | US | disclosed |
| US-20240209000-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS | INTELLIKINE LLC | 2024-06-27 | — | — | US | disclosed |
| US-20240209000-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS | INTELLIKINE LLC | 2024-06-27 | — | — | US | disclosed |
| US-20240025932-A1 | PHOSPHOLIPID COMPOUNDS AND USES THEREOF | GILEAD SCIENCES, INC. | 2024-01-25 | — | — | US | disclosed |
| EP-4041714-B1 | BI-ARYL DIHYDROOROTATE DEHYDROGENASE INHIBITORS | JANSSEN BIOTECH INC (US) | 2023-12-13 | — | — | EP | disclosed |
| US-11840527-B2 | Non-fused thiophene derivatives and their uses | ENYO PHARMA (FR) | 2023-12-12 | — | — | US | disclosed |
| US-5105036-A | Friedel-Crafts catalyst and oxy-substituted cyclic amidines as cocatylsts; preferential formation of p-isomer | BAYER AKTIENGESELLSCHAFT (DE) | 1992-04-14 | — | — | US | disclosed |
| EP-0442115-A1 | Process for nucleus-chlorination of aromatic hydrocarbons | BAYER AG (DE) | 1991-08-21 | — | — | EP | disclosed |
| US-4990707-A | Process for the ring chlorination of aromatic hydrocarbons | BAYER AKTIENGESELLSCHAFT (DE) | 1991-02-05 | — | — | US | disclosed |
| EP-0292824-B1 | PROCESS FOR THE NUCLEAR CHLORINATION OF AROMATIC HYDROCARBONS | BAYER AG (DE) | 1990-08-01 | — | — | EP | disclosed |
| EP-0368063-A1 | Process for the chlorination in the nucleus of aromatic hydrocarbons | BAYER AG (DE) | 1990-05-16 | — | — | EP | disclosed |
| US-4851596-A | Process for nucleus-chlorination of aromatic hydrocarbons | BAYER AKTIENGESELLSCHAFT (DE) | 1989-07-25 | — | — | US | disclosed |
| EP-0291718-A1 | Process for making meta-alkyl phenols | ETHYL CORPORATION (US) | 1988-11-23 | — | — | EP | disclosed |
| US-4774368-A | Process for making meta-alkyl phenols | ETHYL CORPORATION (US) | 1988-09-27 | — | — | US | disclosed |
| JP-S57154134-A | PREPARATION OF HALOGENONEOPHYL CHLORIDE | MITSUI TOATSU CHEM INC | 1982-09-22 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240209000-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS | PIK3CA, PIK3CG, PIK3CD | TSHR 4595/4885ALDH1A1 2457/4885TDP1 1022/4885 |
| US-12030904-B2 | Phospholipid compounds and uses thereof | PHOSPHO1, SGMS2, SGMS1 | TSHR 4567/4885ALDH1A1 3639/4885TDP1 2380/4885 |
| US-20240025932-A1 | PHOSPHOLIPID COMPOUNDS AND USES THEREOF | PHOSPHO1, SGMS2, SGMS1 | TSHR 4567/4885ALDH1A1 3639/4885TDP1 2380/4885 |
| US-11840527-B2 | Non-fused thiophene derivatives and their uses | FTH1, SLC40A1, FECH | TSHR 1240/4885ALDH1A1 1977/4885TDP1 1840/4885 |
| US-12030853-B2 | MASP-2 inhibitors and methods of use | MASP2, METAP2, SPINT2 | TSHR 3550/4885ALDH1A1 4709/4885TDP1 1450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.